NewAmsterdam Pharma (NAMS) Goodwill & Intangibles (2022 - 2025)
Historic Goodwill & Intangibles for NewAmsterdam Pharma (NAMS) over the last 4 years, with Q3 2025 value amounting to $439000.0.
- NewAmsterdam Pharma's Goodwill & Intangibles fell 2596.96% to $439000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $439000.0, marking a year-over-year decrease of 2596.96%. This contributed to the annual value of $534000.0 for FY2024, which is 21411.76% up from last year.
- According to the latest figures from Q3 2025, NewAmsterdam Pharma's Goodwill & Intangibles is $439000.0, which was down 2596.96% from $470000.0 recorded in Q2 2025.
- NewAmsterdam Pharma's Goodwill & Intangibles' 5-year high stood at $84.8 million during Q4 2022, with a 5-year trough of $88887.8 in Q2 2023.
- In the last 4 years, NewAmsterdam Pharma's Goodwill & Intangibles had a median value of $494000.0 in 2024 and averaged $8.9 million.
- Per our database at Business Quant, NewAmsterdam Pharma's Goodwill & Intangibles plummeted by 9979.96% in 2023 and then surged by 50975.75% in 2024.
- Quarter analysis of 4 years shows NewAmsterdam Pharma's Goodwill & Intangibles stood at $84.8 million in 2022, then crashed by 99.8% to $170000.0 in 2023, then soared by 214.12% to $534000.0 in 2024, then fell by 17.79% to $439000.0 in 2025.
- Its Goodwill & Intangibles stands at $439000.0 for Q3 2025, versus $470000.0 for Q2 2025 and $502000.0 for Q1 2025.